O药二线治疗小细胞肺癌不敌化疗,免疫治疗到底适合谁?( 七 )

结合免疫治疗昂贵的费用 , 小细胞肺癌免疫治疗还是要慎重考虑各种因素 。

参考资料:

M Reck et al. LBA5 Efficacy and safety of nivolumab (nivo) monotherapy versus chemotherapy (chemo) in recurrent small cell lung cancer (SCLC): Results from CheckMate 331. Annals of Oncology, Volume 29, Issue suppl_10, 1 December 2018, mdy511.004.

https://doi.org/10.1093/annonc/mdy511.004